NetworkNewsWire Announces Publication on Investment Opportunities Created by Ongoing R&D of Medical Cannabis

NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) — NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (FRT:2VP), an emerging-stage pharmaceutical and IP development company that, through its 80% owned Cannevert Therapeutics Ltd. (“CTL”) subsidiary, seeks to develop the most effective cannabis strains (cultivars) specific to pain, nausea, epilepsy and PTSD, solving the critical need for clinical data to support medical marijuana claims.

The publication, titled, “Investors Could Reap Global Rewards of Research into Medical Cannabis Science,” highlights focused and increased efforts in the research and development of the use of cannabis for a variety of medicinal purposes.

To view the full publication, visit: https://www.networknewswire.com/investors-reap-global-rewards-research-medical-cannabis-science/

“With cannabis set to become legal for recreational use in July 2018 in Canada, and usage of the product for medical purposes steadily rising both

... read more at: https://globenewswire.com/news-release/2017/12/04/1219990/0/en/NetworkNewsWire-Announces-Publication-on-Investment-Opportunities-Created-by-Ongoing-R-D-of-Medical-Cannabis.html

by

Leave a Reply

Your email address will not be published. Required fields are marked *